These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28350900)

  • 1. Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
    Doernberg SB; Lodise TP; Thaden JT; Munita JM; Cosgrove SE; Arias CA; Boucher HW; Corey GR; Lowy FD; Murray B; Miller LG; Holland TL;
    Clin Infect Dis; 2017 Mar; 64(suppl_1):S24-S29. PubMed ID: 28350900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review.
    Doernberg SB; Arias CA; Altman DR; Babiker A; Boucher HW; Creech CB; Cosgrove SE; Evans SR; Fowler VG; Fritz SA; Hamasaki T; Kelly BJ; Leal SM; Liu C; Lodise TP; Miller LG; Munita JM; Murray BE; Pettigrew MM; Ruffin F; Scheetz MH; Shopsin B; Tran TT; Turner NA; Williams DJ; Zaharoff S; Holland TL;
    Clin Infect Dis; 2023 Oct; 77(Suppl 4):S295-S304. PubMed ID: 37843115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
    Doi Y; Bonomo RA; Hooper DC; Kaye KS; Johnson JR; Clancy CJ; Thaden JT; Stryjewski ME; van Duin D;
    Clin Infect Dis; 2017 Mar; 64(suppl_1):S30-S35. PubMed ID: 28350901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
    Napolitano LM
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approaches for empiric therapy in Gram-positive sepsis.
    Bassetti M; Ginocchio F; Giacobbe DR
    Minerva Anestesiol; 2011 Aug; 77(8):821-7. PubMed ID: 21730930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance rates in gram-positive bacteria do not drive glycopeptides use.
    Gladstone BP; Cona A; Shamsrizi P; Vilken T; Kern WV; Malek N; Tacconelli E
    PLoS One; 2017; 12(7):e0181358. PubMed ID: 28727741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of daptomycin in the empirical and directed therapy of infections caused by Gram-positive bacteria in the critically ill patient].
    Garnacho-Montero J; Amaya-Villar R; Gómez-Grande ML; Jerez V; Lorente-Ramos L; Loza A; Martínez A; Pozo JC; Sierra R; Pomares J; de la Torre MV; Ortiz C
    Rev Esp Quimioter; 2011 Mar; 24(1):13-24. PubMed ID: 21412665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future trends in the treatment of serious Gram-positive infections.
    Metzger R; Bonatti H; Sawyer R
    Drugs Today (Barc); 2009 Jan; 45(1):33-45. PubMed ID: 19271030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance in gram-positive bacteria.
    Rice LB
    Am J Med; 2006 Jun; 119(6 Suppl 1):S11-9; discussion S62-70. PubMed ID: 16735146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel agents for resistant Gram-positive infections--a review.
    Strahilevitz J; Rubinstein E
    Int J Infect Dis; 2002 Mar; 6 Suppl 1():S38-46. PubMed ID: 12044288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiology of the infection by resistant Gram-positive microorganisms].
    Cercenado E
    Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():6-9. PubMed ID: 27608305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (2005-2010).
    Zhao C; Sun H; Wang H; Liu Y; Hu B; Yu Y; Sun Z; Chu Y; Cao B; Liao K; Lei J; Hu Z; Zhang L; Zhang X; Xu Y; Wang Z; Chen M
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):174-81. PubMed ID: 22521693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro activity of daptomycin against VRE and MRSA strains].
    Aktaş G; Derbentli S
    Mikrobiyol Bul; 2014 Jan; 48(1):123-8. PubMed ID: 24506722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of resistant gram-positive pathogens in the surgical patient.
    Rapp RP
    Surg Infect (Larchmt); 2000; 1(1):39-47. PubMed ID: 12594908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance in gram-positive bacteria.
    Rice LB
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S11-9; discussion S64-73. PubMed ID: 16813977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new.
    David MZ; Dryden M; Gottlieb T; Tattevin P; Gould IM
    Int J Antimicrob Agents; 2017 Sep; 50(3):303-307. PubMed ID: 28666751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characteristics and predictors of mortality among Gram-positive bacteria isolated from bloodstream infections in critically ill patients during a 5-year period (2012-2016).
    Papadimitriou-Olivgeris M; Kolonitsiou F; Karamouzos V; Tsilipounidaki K; Nikolopoulou A; Fligou F; Marangos M; Petinaki E; Spiliopoulou I
    Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):863-869. PubMed ID: 31898796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features and antimicrobial resistance of Gram positive bacterial blood stream infection in patients with hematologic diseases].
    Cao WB; Su D; Chen YM; Zheng YZ; Zhang FK; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):566-9. PubMed ID: 22967420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.